Eblasakimab | Interleukin Related interleukin-related.com

Product Name :
Eblasakimab

Search keywords :
IL-13 Receptor alpha 1

drugId :
null

Target Vo:
Interleukin-13 receptor subunit alpha-1

Target Vo Short Name :
IL13RA1

Moa_Name:
Interleukin-13 receptor subunit alpha-1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Csl Ltd

Active Company_Name :
ASLAN Pharmaceuticals Ltd

Active Indication_Name:
Dermatitis, Atopic

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ATF6 Antibody (YA831)
Phospho-PTEN (Ser380) Antibody
Phospho-IKB alpha (Ser32) Antibody (YA183): Phospho-IKB alpha (Ser32) Antibody (YA183) is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to Phospho-IKB alpha(S32). It can be used for WB,ICC,IP assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts